Barrett & Company’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.09K | Hold |
3,834
| – | – | ﹤0.01% | 494 |
|
|
2025
Q1 | $4.68K | Hold |
3,834
| – | – | ﹤0.01% | 501 |
|
|
2024
Q4 | $4.95K | Hold |
3,834
| – | – | ﹤0.01% | 494 |
|
|
2024
Q3 | $10.5K | Hold |
3,834
| – | – | ﹤0.01% | 424 |
|
|
2024
Q2 | $8.67K | Hold |
3,834
| – | – | ﹤0.01% | 438 |
|
|
2024
Q1 | $9.16K | Hold |
3,834
| – | – | ﹤0.01% | 437 |
|
|
2023
Q4 | $6.36K | Sell |
3,834
-1,150
| -23% | -$1.91K | ﹤0.01% | 452 |
|
|
2023
Q3 | $9.57K | Hold |
4,984
| – | – | 0.01% | 422 |
|
|
2023
Q2 | $7.18K | Hold |
4,984
| – | – | ﹤0.01% | 439 |
|
|
2023
Q1 | $10.5K | Hold |
4,984
| – | – | 0.01% | 383 |
|
|
2022
Q4 | $5.63K | Hold |
4,984
| – | – | ﹤0.01% | 436 |
|
|
2022
Q3 | $5.63K | Buy |
+4,984
| New | +$5.63K | ﹤0.01% | 436 |
|